FDA
-
-
-
-
-
-
-
Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Royalty Pharma acquires drug royalty rights for up to $315 million
-
-
-
-
-
-
-
Royalty Pharma acquires AMVUTTRA royalty for $310 million
-
-
-
-
-
-
-
Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million
-
-
-
-
-
-
-
Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors
-
-
-
-
-
-
-
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo
-
-
-
-
-
-
-
Royalty Pharma (RPRX) PT Raised to $50 at Goldman Sachs
-
322,220 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

